Parathyroid cancer

Seminars in Oncology

Volumn 37, Issue 6, 2010, Pages 580-590

  Sharretts, John M ^a   Kebebew, Electron ^b   Simonds, William F ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CALCIUM; CHORIONIC GONADOTROPIN; CINACALCET; CYCLOPHOSPHAMIDE; DACARBAZINE; DENOSUMAB; DNA; FLUOROURACIL; GLYCOGEN SYNTHASE KINASE 3BETA; KI 67 ANTIGEN; PAMIDRONIC ACID; PARAFIBROMIN; PARATHYROID HORMONE; PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; ZOLEDRONIC ACID;

ARTICLE; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURGERY; DEATH; DIAGNOSTIC IMAGING; DISEASE COURSE; DNA DETERMINATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; IMMUNIZATION; LABORATORY TEST; METASTASIS; NONHUMAN; PARATHYROID CARCINOMA; PARATHYROID GLAND; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SOMATIC MUTATION; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASOUND;

DISEASE PROGRESSION; HUMANS; HYPERCALCEMIA; MUTATION; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 78650229246     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.10.013     Document Type: Article

References (123)

1. E.C. Holmes, D.L. Morton, and A.S. Ketcham Parathyroid carcinoma: a collective review Ann Surg 169 1969 631 640
2. E. Shane, and J.P. Bilezikian Parathyroid carcinoma: a review of 62 patients Endocr Rev 3 1982 218 226
3. T. Obara, and Y. Fujimoto Diagnosis and treatment of patients with parathyroid carcinoma: an update and review World J Surg 15 1991 738 744
4. A.G. Wynne, J. van Heerden, J.A. Carney, and L.A. Fitzpatrick Parathyroid carcinoma: clinical and pathologic features in 43 patients Medicine (Baltimore) 71 1992 197 205
5. J.M. Ruda, C.S. Hollenbeak, and B.C. Stack Jr A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 Otolaryngol Head Neck Surg 132 2005 359 372
6. J.B. Koea, and J.H. Shaw Parathyroid cancer: biology and management Surg Oncol 8 1999 155 165
7. Y. Fujimoto, T. Obara, Y. Ito, K. Kanazawa, Y. Aiyoshi, and M. Nobori Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection World J Surg 8 1984 392 400
8. P.K. Lee, S.L. Jarosek, B.A. Virnig, M. Evasovich, and T.M. Tuttle Trends in the incidence andtreatment of parathyroid cancer in the United States Cancer 109 2007 1736 1741
9. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, and H.R. Menck Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 86 1999 538 544
10. A.B. Schneider, T.C. Gierlowski, E. Shore-Freedman, M. Stovall, E. Ron, and J. Lubin Dose-response relationships for radiation-induced hyperparathyroidism J Clin Endocrinol Metab 80 1995 254 257
11. E. Holmberg, A. Wallgren, L.E. Holm, M. Lundell, and P. Karlsson Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy Radiat Res 158 2002 418 423
12. T. Rasmuson, L. Damber, L. Johansson, R. Johansson, and L.G. Larsson Increased incidence of parathyroid adenomas following X-ray treatment of benign diseases in the cervical spine in adult patients Clin Endocrinol 57 2002 731 734
13. S. Tezelman, J.M. Rodriguez, W. Shen, A.E. Siperstein, Q.Y. Duh, and O.H. Clark Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy J Am Coll Surg 180 1995 81 87
14. T. McMullen, G. Bodie, and A. Gill Hyperparathyroidism after irradiation for childhood malignancy Int J Radiat Oncol Biol Phys 73 2009 1164 1168
15. A. Katz, and G.D. Braunstein Clinical, biochemical, and pathologic features of radiation-associated hyperparathyroidism Arch Intern Med 143 1983 79 82
16. T.J. Christmas, C.R. Chapple, J.G. Noble, E.J. Milroy, and A.G. Cowie Hyperparathyroidism after neck irradiation Br J Surg 75 1988 873 874
17. J.P. Ireland, S.J. Fleming, D.A. Levison, W.R. Cattell, and L.R. Baker Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck J Clin Pathol 38 1985 1114 1118
18. M.A. Mashburn, G.D. Chonkich, D.R. Chase, and G.H. Petti Jr Parathyroid carcinoma: two new casesdiagnosis, therapy, and treatment Laryngoscope 97 1987 215 218
19. C.E. Jackson, R.A. Norum, and S.B. Boyd Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome Surgery 108 1990 1006 1012
20. K.J. Bradley, M.R. Hobbs, and I.D. Buley Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome J Intern Med 257 2005 18 26
21. J.D. Chen, C. Morrison, C. Zhang, K. Kahnoski, J.D. Carpten, and B.T. Teh Hyperparathyroidism-jaw tumour syndrome J Intern Med 253 2003 634 642
22. L.E. Mallette, S. Malini, M.P. Rappaport, and J.L. Kirkland Familial cystic parathyroid adenomatosis Ann Intern Med 107 1987 54 60
23. J.D. Carpten, C.M. Robbins, and A. Villablanca HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome Nature Genet 32 2002 676 680
24. X. Shi, M. Chang, A.J. Wolf, and C.H. Chang Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme Mol Cell Biol 17 1997 1160 1169
25. P.J. Newey, M.R. Bowl, and R.V. Thakker Parafibrominfunctional insights J Intern Med 266 2009 84 98
26. W.F. Simonds, C.M. Robbins, S.K. Agarwal, G.N. Hendy, J.D. Carpten, and S.J. Marx Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome J Clin Endocrinol Metab 89 2004 96 102
27. A. Villablanca, A. Calender, and L. Forsberg Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) J Med Genet 41 2004 e32
28. F. Cetani, E. Pardi, and S. Borsari Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors J Clin Endocrinol Metab 89 2004 5583 5591
29. K.J. Bradley, B.M. Cavaco, M.R. Bowl, B. Harding, A. Young, and R.V. Thakker Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism J Med Genet 42 2005 e51
30. K.J. Bradley, B.M. Cavaco, and M.R. Bowl Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours Clin Endocrinol 64 2006 299 306
31. V. Guarnieri, A. Scillitani, and L.A. Muscarella Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance J Clin Endocrinol Metab 91 2006 2827 2832
32. N. Mizusawa, S. Uchino, and T. Iwata Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome Clin Endocrinol 65 2006 9 16
33. T.G. Kelly, T.M. Shattuck, and M. Reyes-Mugica Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation J Bone Miner Res 21 2006 1666 1671
34. G. Masi, L. Barzon, and M. Iacobone Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism Endocr Relat Cancer 15 2008 1115 1126
35. V.M. Howell, C.J. Haven, and K. Kahnoski HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours J Med Genet 40 2003 657 663
36. F. Cetani, E. Pardi, and S. Borsari Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors J Clin Endocrinol Metab 89 2004 5583 5591
37. T.M. Shattuck, S. Valimaki, and T. Obara Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma N Engl J Med 349 2003 1722 1729
38. C.J. Haven, M. van Puijenbroek, and M.H. Tan Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas Clin Endocrinol 67 2007 370 376
39. M.A. Hahn, V. Howell, and A. Gill CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors Endocr Relat Cancer 17 2010 273 282
40. K.M. Hewitt, P.K. Sharma, W. Samowitz, and M. Hobbs Aberrant methylation of the HRPT2 gene in parathyroid carcinoma Ann Otol Rhinol Laryngol 116 2007 928 933
41. S. Corbetta, V. Vaira, and V. Guarnieri Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue Endocr Relat Cancer 17 2010 135 146
42. L.J. Krebs, T.M. Shattuck, and A. Arnold HRPT2 mutational analysis of typical sporadic parathyroid adenomas J Clin Endocrinol Metab 90 2005 5015 5017
43. C.J. Haven, V.M. Howell, and P.H. Eilers Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype Cancer Res 64 2004 7405 7411
44. S. Kytl, F. Farnebo, and T. Obara Patterns of chromosomal imbalances in parathyroid carcinomas Am J Pathol 157 2000 579 586
45. O. Rozenblatt-Rosen, C.M. Hughes, and S.J. Nannepaga The parafibromin tumor suppressor protein is part of a human Paf1 complex Mol Cell Biol 25 2005 612 620
46. L.J. Farber, E.J. Kort, P. Wang, J. Chen, and B.T. Teh The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA Mol Carcinog 49 2010 215 223
47. O. Rozenblatt-Rosen, T. Nagaike, and J.M. Francis The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors Proc Natl Acad Sci U S A 106 2009 755 760
48. G.E. Woodard, L. Lin, J.H. Zhang, S.K. Agarwal, S.J. Marx, and W.F. Simonds Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression Oncogene 24 2005 1272 1276
49. Y.J. Yang, J.W. Han, H.D. Youn, and E.J. Cho The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression Nucleic Acids Res 38 2010 382 390
50. J. Zhao, A. Yart, and S. Frigerio Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene Oncogene 26 2007 3440 3449
51. C. Juhlin, C. Larsson, and T. Yakoleva Loss of parafibromin expression in a subset of parathyroid adenomas Endocr Relat Cancer 13 2006 509 523
52. F. Cetani, E. Ambrogini, and P. Viacava Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156 2007 547 554
53. R.Y. Shih, S. Fackler, S. Maturo, M.W. True, J. Brennan, and D. Wells Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation Endocr Pract 15 2009 567 572
54. M. Sato, A. Miyauchi, and H. Namihira A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma Endocrine 12 2000 223 226
55. A. Agha, R. Carpenter, S. Bhattacharya, S.J. Edmonson, E. Carlsen, and J.P. Monson Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity J Endocrinol Invest 30 2007 145 149
56. S. Dionisi, S. Minisola, and J. Pepe Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis Mayo Clin Proc 77 2002 866 869
57. P.J. Jenkins, M.A. Satta, and M. Simmgen Metastatic parathyroid carcinoma in the MEN2A syndrome Clin Endocrinol 47 1997 747 751
58. V.L. Cryns, A. Thor, and H.J. Xu Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma N Engl J Med 330 1994 757 761
59. T.M. Shattuck, T.S. Kim, and J. Costa Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma Clin Endocrinol 59 2003 180 189
60. F. Farnebo, G. Auer, and L.O. Farnebo Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease World J Surg 23 1999 68 74
61. M.P. Vargas, H.I. Vargas, D.E. Kleiner, and M.J. Merino The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors Mod Pathol 10 1997 12 17
62. G.G. Fernandez-Ranvier, and E. Khanafshar Defining a molecular phenotype for benign and malignant parathyroid tumors Cancer 115 2009 334 344
63. J.P. Hakim, and M.A. Levine Absence of p53 point mutations in parathyroid adenoma andcarcinoma J Clin Endocrinol Metab 78 1994 103 106
64. V.L. Cryns, M.P. Rubio, A.D. Thor, D.N. Louis, and A. Arnold p53 abnormalities in human parathyroid carcinoma J Clin Endocrinol Metab 78 1994 1320 1324
65. S.K. Agarwal, E. Schrock, and M.B. Kester Comparative genomic hybridization analysis of human parathyroid tumors Cancer GenetCytogenet 106 1998 30 36
66. Y. Tominaga, M. Numano, and K. Uchida Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case Surg Today 25 1995 984 986
67. A.I. Djema, M.D. Mahmoud, P. Collin, and M.F. Heymann [Tertiary hyperparathyroidism: parathyroid cancer with liver metastases in a hemodialyzed patient] Nephrologie 19 1998 121 123
68. M.W. Khan, E.M. Worcester, F.H. Straus 2nd, S. Khan, V. Staszak, and E.L. Kaplan Parathyroid carcinoma in secondary and tertiary hyperparathyroidism J Am Coll Surg 199 2004 312 319
69. Y. Tominaga, T. Tsuzuki, and S. Matsuoka Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease World J Surg 32 2008 815 821
70. E. Shane Clinical review 122: Parathyroid carcinoma J Clin Endocrinol Metab 86 2001 485 493
71. N.L. Busaidy, C. Jimenez, and M.A. Habra Parathyroid carcinoma: a 22-year experience Head Neck 26 2004 716 726
72. G.G. Fernandez-Ranvier, E. Khanafshar, and K. Jensen Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110 2007 255 264
73. S.J. Silverberg, and J.P. Bilezikian The diagnosis and management of asymptomatic primary hyperparathyroidism Nat Clin Pract Endocrinol Metab 2 2006 494 503
74. C. Marcocci, F. Cetani, M.R. Rubin, S.J. Silverberg, A. Pinchera, and J.P. Bilezikian Parathyroid carcinoma J Bone Miner Res 23 2008 1869 1880
75. C.L. Messerer, S.P. Bugis, C. Baliski, and S.M. Wiseman Normocalcemic parathyroid carcinoma: an unusual clinical presentation World J Surg Oncol 4 2006 10
76. E. Kebebew, C. Arici, Q.Y. Duh, and O.H. Clark Localization and reoperation results for persistent and recurrent parathyroid carcinoma Arch Surg 136 2001 878 885
77. J.L. Stock, B.D. Weintraub, S.W. Rosen, G.D. Aurbach, A.M. Spiegel, and S.J. Marx Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism J Clin Endocrinol Metab 54 1982 57 63
78. M.R. Rubin, J.P. Bilezikian, S. Birken, and S.J. Silverberg Human chorionic gonadotropin measurements in parathyroid carcinoma Eur J Endocrinol 159 2008 469 474
79. M.R. Rubin, S.J. Silverberg, and P. D'Amour An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma Clin Chem 53 2007 1470 1476
80. H. Hara, A. Igarashi, and Y. Yano Ultrasonographic features of parathyroid carcinoma Endocr J 48 2001 213 217
81. R. Tamler, M.S. Lewis, V.A. LiVolsi, and E.M. Genden Parathyroid carcinoma: ultrasonographic and histologic features Thyroid 15 2005 744 745
82. C. Spinelli, A.G. Bonadio, P. Berti, G. Materazzi, and P. Miccoli Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology J Endocrinol Invest 23 2000 255 257
83. G. Agarwal, S. Dhingra, S.K. Mishra, and N. Krishnani Implantation of parathyroid carcinoma along fine needle aspiration track Langenbecks Arch Surg 391 2006 623 626
84. E. Kebebew Parathyroid carcinoma Curr Treat Options Oncol 2 2001 347 354
85. C.A. Wang, and R.D. Gaz Natural history of parathyroid carcinoma Diagnosis, treatment, and results Am J Surg 149 1985 522 527
86. R.A. DeLellis Parathyroid carcinoma: an overview Adv Anat Pathol 12 2005 53 61
87. T. Obara, Y. Fujimoto, and A. Hirayama Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma Cancer 65 1990 1789 1793
88. K. Kameyama, and H. Takami Double parathyroid carcinoma Endocr J 50 2003 477 479
89. P. Sahasranam, M.T. Tran, H. Mohamed, and T.C. Friedman Multiglandular parathyroid carcinoma: a case report and brief review South Med J 100 2007 841 844
90. A. Schantz, and B. Castleman Parathyroid carcinoma A study of 70 cases Cancer 31 1973 600 605
91. M.H. Tan, C. Morrison, and P. Wang Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma Clin Cancer Res 10 2004 6629 6637
92. A.J. Gill, A. Clarkson, and O. Gimm Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias Am J Surg Pathol 30 2006 1140 1149
93. C.C. Juhlin, A. Villablanca, and K. Sandelin Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification Endocr Relat Cancer 14 2007 501 512
94. V.M. Howell, A. Gill, and A. Clarkson Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma Clin Endocrinol Metab 94 2009 434 441
95. G.C. Abbona, M. Papotti, G. Gasparri, and G. Bussolati Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining Hum Pathol 26 1995 135 138
96. L.A. Erickson, L. Jin, P. Wollan, G.B. Thompson, J.A. van Heerden, and R.V. Lloyd Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein Am J Surg Pathol 23 1999 288 295
97. C.J. Haven, M. van Puijenbroek, M. Karperien, G.J. Fleuren, and H. Morreau Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and11q in parathyroid carcinoma J Pathol 202 2004 86 94
98. N. Bergero, R. De Pompa, and C. Sacerdote Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases Hum Pathol 36 2005 908 914
99. M. Iihara, T. Okamoto, and R. Suzuki Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis Surgery 142 2007 936 943
100. C.C. Juhlin, F. Haglund, and A. Villablanca Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas Int J Oncol 34 2009 481 492
101. B.J. Wilkins, and J.S. Lewis Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery Head Neck Pathol 3 2009 140 149
102. G.G. Fernandez-Ranvier, K. Jensen, and E. Khanafshar Nonfunctioning parathyroid carcinoma: case report and review of literature Endocr Pract 13 2007 750 757
103. N.G. Ordonez, M.L. Ibanez, N.A. Samaan, and R.C. Hickey Immunoperoxidase study of uncommon parathyroid tumors Report of two cases of nonfunctioning parathyroid carcinoma and one intrathyroid parathyroid tumor-producing amyloid Am J Surg Pathol 7 1983 535 542
104. H. Yamashita, S. Noguchi, N. Murakami, M. Toda, M. Adachi, and T. Daa Immunohistological study of nonfunctional parathyroid carcinoma Report of a case Acta Pathol Jpn 42 1992 279 285
105. C.A. Wang, and R.D. Gaz Natural history of parathyroid carcinoma Diagnosis, treatment, and results Am J Surg 149 1985 522 527
106. T. Obara, T. Okamoto, and Y. Ito Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma Surgery 114 1993 1040 1048
107. H. Koyano, Y. Shishiba, and T. Shimizu Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma Intern Med 33 1994 697 702
108. M.W. Flye, and M.F. Brennan Surgical resection of metastatic parathyroid carcinoma Ann Surg 193 1981 425 435
109. Y. Fujimoto, T. Obara, Y. Ito, T. Kodama, M. Nobori, and S. Ebihara Localization and surgical resection of metastatic parathyroid carcinoma World J Surg 10 1986 539 547
110. M. Tochio, H. Takaki, and K. Yamakado A case report of 20 lung radiofrequency ablation sessions for 50 lung metastases from parathyroid carcinoma causing hyperparathyroidism Cardiovasc Intervent Radiol 33 2010 657 659
111. A. Artinyan, E. Guzman, and E. Maghami Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization J Clin Oncol 26 2008 4039 4041
112. F.L. Montenegro, M.C. Chammas, A.G. Juliano, C.R. Cernea, and A.C. Cordeiro Ethanol injection under ultrasound guidance to palliate unresectable parathyroid carcinoma Arq Bras Endocrinol Metabol 52 2008 707 711
113. D.B. Calandra, G. Chejfec, B.K. Foy, A.M. Lawrence, and E. Paloyan Parathyroid carcinoma: biochemical and pathologic response to DTIC Surgery 96 1984 1132 1137
114. R.M. Bukowski, L. Sheeler, J. Cunningham, and C. Esselstyn Successful combination chemotherapy for metastatic parathyroid carcinoma Arch Intern Med 144 1984 399 400
115. E.M. Vega, and C.A. Mautalen Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma Medicina (B Aires) 51 1991 106 110
116. E.D. Szmuilowicz, and R.D. Utiger A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy Nat Clin Pract Endocrinol Metab 2 2006 291 296
117. M.T. Collins, M.C. Skarulis, J.P. Bilezikian, S.J. Silverberg, A.M. Spiegel, and S.J. Marx Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent J Clin Endocrinol Metab 83 1998 1083 1088
118. S.J. Silverberg, M.R. Rubin, and C. Faiman Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma J Clin Endocrinol Metab 92 2007 3803 3808
119. A.R. Bradwell, and T.C. Harvey Control of hypercalcaemia of parathyroid carcinoma by immunisation Lancet 353 1999 370 373
120. D. Betea, A.R. Bradwell, and T.C. Harvey Hormonal and biochemical normalization and tumor shrinkage induced by antiparathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma J Clin Endocrinol Metab 89 2004 3413 3420
121. F. Lumachi, A. Brunello, A. Roma, and U. Basso Cancer-induced hypercalcemia Anticancer Res 29 2009 1551 1555
122. K. Sandelin, G. Auer, L. Bondeson, L. Grimelius, and L.O. Farnebo Prognostic factors in parathyroid cancer: a review of 95 cases World J Surg 16 1992 724 731
123. J.C. Hundley, D.A. Albertson, R.F. Bradley, and E.A. Levine Resection of pulmonary metastasis from parathyroid carcinoma Am Surg 69 2003 779 783